gipfelpuls

Greenda

Greenda is a Munich-based agritech startup with an AI-powered pest management platform built for agricultural cooperatives and the farmers they serve. From a single dashboard, cooperative technicians get AI-assisted support to diagnose pests and diseases, manage every plot across their territory, and keep digital-notebook compliance records up to date, replacing scattered spreadsheets and paperwork with one connected system. Farmers, in turn, stay linked to their cooperative directly from the field, reporting issues and receiving guidance through a simple mobile experience designed for low digital literacy. Greenda turns everyday field observations into practical, plot-level intelligence. Each diagnosis and treatment decision compounds into shared pest intelligence over time, helping cooperatives and their farmers move from reacting to outbreaks toward anticipating them.

We at supernutural are a Munich-based food tech startup that builds machines that produce freshly pressed nut creams from nuts. Our business case, however, is nuts as a service. With this model, we have already achieved success in 40 countries, primarily B2B, and have been awarded the German Sustainability Prize and the Bavarian Export Prize for our commitment. In addition to the hotel industry, our customers include the world’s best corporate companies, professional sports clubs, and an increasing number of private individuals. With freshly pressed nut cream, as pioneers we have created a new category that has impact in the areas of healthy snacking, waste reduction, and food waste, and is disruptive for industrially manufactured nut creams – but without palm oil, sugar, or additives.

VAROLIS GmbH

Honeybees are essential for food production, resilient agriculture, and our ecosystem. At the same time, the parasitic Varroa mite threatens our honeybees. By now, every colony is infested, and without treatment, colonies collapse within 2 years. Options for protecting bees from Varroa mites are limited, unreliable, and outdated. VAROLIS is committed to obtaining regulatory approval for our novel active ingredient, LIMITEX, as a veterinary product. LIMITEX is highly efficient and easy to use. It is well tolerated by bees and leaves no residues in bee products. The data have been tested and validated multiple times in field trials under beekeeping conditions. VAROLIS has freedom to operate and licenses for all necessary patents. The market size exceeds 2 billion euros annually, production costs are low, and the product is highly profitable. Based on conservative assumptions, VAROLIS will achieve return on investment just 2 years after market launch. Our preclinical data package and preliminary work on quality and safety for LIMITEX reduce the risk in the approval process. Our team has experience as entrepreneurs, scientists, beekeepers, and in drug development. Additionally, we are supported by a broad team of consultants and experts. Beyond the positive impact on our environment, our B2B and B2C business model opens economically promising opportunities. To achieve our goal, we now need financial support from strategic partners who want to accompany us on our path toward improved bee protection, resilient agriculture, food security, biodiversity, and healthy ecosystems.